Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Cannabis Use Disorder
NCT03980561Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Jan 2020; status: completed.
02
Drugs
varenicline
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT03980561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03980561.